Epicatechin regulation of mitochondrial structure and function is opioid receptor dependent

Molecular Nutrition and Food Research

Volumn 57, Issue 6, 2013, Pages 1007-1014

  Panneerselvam, Mathivadhani ^a   Ali, Sameh S ^a,b,c   Finley, J Cameron ^a   Kellerhals, Sarah E ^a   Migita, Michael Y ^a,b   Head, Brian P ^a,b   Patel, Piyush M ^a,b   Roth, David M ^a,b   Patel, Hemal H ^a,b  

^a School of Medicine   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^c Zewail City of Science and Technology   (Egypt)

Author keywords

Epicatechin; Heart; Opioids; Superoxide

Indexed keywords

CALCIUM; CATECHIN; DELTA OPIATE RECEPTOR; REACTIVE OXYGEN METABOLITE;

ANIMAL; ARTICLE; C57BL MOUSE; CACAO; CELL RESPIRATION; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; HEART MITOCHONDRION; MALE; METABOLISM; MITOCHONDRIAL MEMBRANE; MOUSE; ULTRASTRUCTURE;

ANIMALS; CACAO; CALCIUM; CATECHIN; CELL RESPIRATION; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA, HEART; MITOCHONDRIAL MEMBRANES; REACTIVE OXYGEN SPECIES; RECEPTORS, OPIOID, DELTA;

MUS; THEOBROMA CACAO;

EID: 84878897773     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201300026     Document Type: Article

References (33)

1. Rosenberg, P., Mitochondrial dysfunction and heart disease. Mitochondrion 2004, 4, 621-628.
2. Chen, L., Knowlton, A. A., Mitochondrial dynamics in heart failure. Congest. Heart Fail. 2011, 17, 257-261.
3. Chang, W. T., Li, J., Haung, H. H., Liu, H. et al., Baicalein protects against doxorubicin-induced cardiotoxicity by attenuation of mitochondrial oxidant injury and JNK activation. J. Cell Biochem. 2011, 112, 2873-2881.
4. Yang, E. J., Min, J. S., Ku, H. Y., Choi, H. S. et al., Isoliquiritigenin isolated from Glycyrrhiza uralensis protects neuronal cells against glutamate-induced mitochondrial dysfunction. Biochem. Biophys. Res. Commun. 2012, 421, 658-664.
5. Engler, M. B., Engler, M. M., The emerging role of flavonoid-rich cocoa and chocolate in cardiovascular health and disease. Nutr. Rev. 2006, 64, 109-118.
6. Taub, P. R., Ramirez-Sanchez, I., Ciaraldi, T. P., Perkins, G. et al., Alterations in skeletal muscle indicators of mitochondrial structure and biogenesis in patients with type 2 diabetes and heart failure: effects of epicatechin rich cocoa. Clin. Transl. Sci. 2012, 5, 43-47.
7. Huttemann, M., Lee, I., and Malek, M. H., (-)-Epicatechin maintains endurance training adaptation in mice after 14 days of detraining. FASEB J. 2012, 26, 1413-1422.
8. Nogueira, L., Ramirez-Sanchez, I., Perkins, G. A., Murphy, A. et al., (-)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle. J. Physiol. 2011, 589, 4615-4631.
9. Panneerselvam, M., Tsutsumi, Y. M., Bonds, J. A., Horikawa, Y. T. et al., Dark chocolate receptors: epicatechin-induced cardiac protection is dependent on delta-opioid receptor stimulation. Am. J. Physiol. Heart Circ. Physiol. 2010, 299, H1604-H1609.
10. Li, L., Zhang, H., Li, T., Zhang, B., Involvement of adenosine monophosphate-activated protein kinase in morphine-induced cardioprotection. J. Surg. Res. 2011, 169, 179-187.
11. Peart, J. N., Gross, G. J., Cardioprotective effects of acute and chronic opioid treatment are mediated via different signaling pathways. Am. J. Physiol. Heart Circ. Physiol. 2006, 291, H1746-H1753.
12. Cao, Z., Liu, L., Van Winkle, D. M., Activation of delta- and kappa-opioid receptors by opioid peptides protects cardiomyocytes via KATP channels. Am. J. Physiol. Heart Circ. Physiol. 2003, 285, H1032-H1039.
13. Fang, X., Tang, W., Sun, S., Weil, M. H., Delta-opioid-induced pharmacologic myocardial hibernation during cardiopulmonary resuscitation. Crit. Care Med. 2006, 34, S486-S489.
14. Schultz, J. E., Gross, G. J., Opioids and cardioprotection. Pharmacol. Ther. 2001, 89, 123-137.
15. Ali, S. S., Marcondes, M. C., Bajova, H., Dugan, L. L. et al., Metabolic depression and increased reactive oxygen species production by isolated mitochondria at moderately lower temperatures. J. Biol. Chem. 2010, 285, 32522-32528.
16. Gabbita, S. P., Butterfield, D. A., Hensley, K., Shaw, W. et al., Aging and caloric restriction affect mitochondrial respiration and lipid membrane status: an electron paramagnetic resonance investigation. Free Radic. Biol. Med. 1997, 23, 191-201.
17. Gabbita, S. P., Subramaniam, R., Allouch, F., Carney, J. M. et al., Effects of mitochondrial respiratory stimulation on membrane lipids and proteins: an electron paramagnetic resonance investigation. Biochim. Biophys. Acta. 1998, 1372, 163-173.
18. Xu, Z., Ji, X., Boysen, P. G., Exogenous nitric oxide generates ROS and induces cardioprotection: involvement of PKG, mitochondrial KATP channels, and ERK. Am. J. Physiol. Heart Circ. Physiol. 2004, 286, H1433-H1440.
19. Rosc-Schluter, B. I., Hauselmann, S. P., Lorenz, V., Mochizuki, M. et al., NOX2-derived reactive oxygen species are crucial for CD29-induced pro-survival signalling in cardiomyocytes. Cardiovasc. Res. 2012, 93, 454-462.
20. Ventura, C., Spurgeon, H., Lakatta, E. G., Guarnieri, C. et al., Kappa and delta opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons. Circ. Res. 1992, 70, 66-81.
21. Yang, Y., Xia, X., Zhang, Y., Wang, Q. et al., Delta-opioid receptor activation attenuates oxidative injury in the ischemic rat brain. BMC Biol. 2009, 7, 55.
22. McPherson, B. C., Yao, Z., Morphine mimics preconditioning via free radical signals and mitochondrial K(ATP) channels in myocytes. Circulation 2001, 103, 290-295.
23. Dorta, D. J., Pigoso, A. A., Mingatto, F. E., Rodrigues, T. et al., The interaction of flavonoids with mitochondria: effects on energetic processes. Chem. Biol. Interact. 2005, 152, 67-78.
24. Wagner, B. A., Buettner, G. R., Burnes, C. P., Free radical-mediated lipid peroxidation in cells: oxidizability is a function of cell lipid bis-allylic hydrogen content. Biochemistry 1994, 33, 4449-4453.
25. Dean, R. T., Fu, S., Stocker, R., Davies, M. J., Biochemistry and pathology of radical-mediated protein oxidation. Biochem. J. 1997, 324, 1-18.
26. Schraufstatter, I. U., Hyslop, P. A., Jackson, J., Cochrane, C. C., Oxidant injury of cells. Int. J. Tis. React. 1987, 9, 317-324.
27. VandenHoek, T. L., Becker, L. B., Shao, Z., Li, C. et al., Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes. J. Biol. Chem. 1998, 273, 18092-18098.
28. Moncada, S., Higgs, E. A., Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB J. 1995, 9, 1319-1330.
29. Xu, J. Z., Yeung, S. Y., Chang, Q., Huang, Y. et al., Comparison of antioxidant activity and bioavailability of tea epicatechins with their epimers. Br. J. Nutr. 2004, 91, 873-881.
30. Patel, H. H., Hsu, A., Gross, G. J., Delayed cardioprotection is mediated via a non-peptide delta opioid agonist, SNC-121, independent of opioid receptor stimulation. Bas. Res. Cardiol. 2004, 99, 38-45.
31. Patel, H. H., Hsu, A., Moore, J., Gross, G. J., BW373U86, a delta opioid agonist, partially mediates delayed cardioprotection via a free radical mechanism that is independent of opioid receptor stimulation. J. Mol. Cell. Cardiol. 2001, 33, 1455-1465.
32. Lagoa, R., Graziani, I., Lopez-Sanchez, C., Garcia-Martinez, V. et al., Complex I and cytochrome c are molecular targets of flavonoids that inhibit hydrogen peroxide production by mitochondria. Biochim. Biophys. Acta 2011, 1807, 1562-1572.
33. Ananthan, S., Johnson, C. A., Carter, R. L., Clayton, S. D. et al., Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety. J. Med. Chem. 1998, 41, 2872-2881.